Quality of care assessment in chronic liver disease
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Fasiha Kanwal – 20 January 2015 – Watch a video presentation of this article
Myung Han Hyun, Sang Mi Chung – 20 January 2015
Shengbiao Li, Jingyi Guo, Zhongfu Ying, Shen Chen, Liang Yang, Keshi Chen, Qi Long, Dajiang Qin, Duanqing Pei, Xingguo Liu – 20 January 2015 – Valproic acid (VPA) is widely used to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy, but potentially causes idiosyncratic liver injury. Alpers‐Huttenlocher syndrome (AHS), a neurometabolic disorder caused by mutations in mitochondrial DNA polymerase gamma (POLG), is associated with an increased risk of developing fatal VPA hepatotoxicity.
Chunping Wang, Ke‐Qin Hu, Yongping Yang – 20 January 2015
Michael L. Volk – 20 January 2015 – Watch a video presentation of this article
Jayant A. Talwalkar – 20 January 2015 – Watch a video presentation of this article
Amy K. Kim, Amit G. Singal – 20 January 2015 – Watch a video presentation of this article
Amy K. Kim, Amit G. Singal – 20 January 2015 – Watch a video presentation of this article
Christine E. McLaren, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, James C. Barton, Paul C. Adams, Justin B. Goh, Cameron J. McDonald, Lawrie W. Powell, Lyle C. Gurrin, Katrina J. Allen, Deborah A. Nickerson, Tin Louie, Grant A. Ramm, Gregory J. Anderson, Gordon D.